Kazuki Watanabe,Mitsuhito Ota,Takashi Anan
Kazuki Watanabe
GLP-1 Receptor Agonist Therapy in Patients With Extragenital Lichen Sclerosus [0.03%]
关于外阴硬化性萎缩之外的硬化性萎缩性苔藓患者的GLP-1受体激动剂治疗
Joshua Prenner,Kathryn Rentfro,Ruth Ann Vleugels et al.
Joshua Prenner et al.
Deuterated Pentoxifylline Analog in the Treatment of Necrobiosis Lipoidica: A Nonrandomized Clinical Trial [0.03%]
尿囊素五味子醇酯类似物治疗脂样 necrobiosis的临床研究
Ayelet I Rubenstein,Maya Das,Mary Nyberg et al.
Ayelet I Rubenstein et al.
Importance: Necrobiosis lipoidica (NL) is a rare, chronic granulomatous skin disease for which no US Food and Drug Administration (FDA)-approved treatments exist. PCS499, an oral deuterated pentoxifylline analog, may offe...
Xin Liu,Yufei Wu,Zhuokun Liu et al.
Xin Liu et al.
Navigating the Diagnostic Maze of Cutaneous Squamous Cell Carcinoma Nodal Assessment [0.03%]
皮肤鳞状细胞癌淋巴结评估诊断迷宫的导航
Selin Tokez,Marlies Wakkee
Selin Tokez
Diagnostic Modalities and Nodal Staging in High-Risk Cutaneous Squamous Cell Carcinoma [0.03%]
高危皮肤鳞状细胞癌的诊断方式和淋巴结分期
Carla Ferrándiz-Pulido,Álvaro Gómez-Tomás,Sahyly Siurana et al.
Carla Ferrándiz-Pulido et al.
Importance: Early detection of nodal metastases in high-risk cutaneous squamous cell carcinoma (cSCC) is crucial, yet the optimal baseline staging approach remains uncertain. ...
Hywel Charles Williams
Hywel Charles Williams
Woo Chiao Tay,Suat Hoon Tan,Ziying Vanessa Lim
Woo Chiao Tay
Omission of Supplement 1 [0.03%]
附录一略记
Published Erratum
JAMA dermatology. 2026 Apr 1;162(4):427. DOI:10.1001/jamadermatol.2026.0889 2026
Cutaneous Eruptions and Lifileucel/Interleukin 2 in Individuals With Metastatic Melanoma [0.03%]
肢端黑色素瘤患者使用Lifileucel/干扰素二期临床试验中皮肤不良事件的评估
Jordan T Said,Yunxi Li,Nakisa Sadeghi et al.
Jordan T Said et al.
Importance: Lifileucel is a first-in-class autologous tumor-infiltrating lymphocyte (TIL) therapy for advanced/metastatic melanoma with progression after anti-programmed cell death protein 1 (PD-1) therapy and/or BRAF inh...